Literature DB >> 16080962

Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis.

Panagiotis Tsirigotis1, Sotirios Papageorgiou, Danai Abatzis, Sofia Athanatou, Constantinos Girkas, Vasiliki Pappa, Constantinos Pangalos, Efstathios Papageorgiou, John Dervenoulas, Sotirios Raptis.   

Abstract

Tetrasomy 8 is an extremely rare chromosome abnormality, one that has been reported in only a few cases with myeloid malignancies. The majority of reported cases consist of acute myelogenous leukemias (AML) of monocytic lineage. In slightly more than half of the patients, tetrasomy 8 was the single cytogenetic abnormality. Fluorescence in situ hybridization revealed tetrasomy 8 and trisomy 8 concurrently in all but one of the bone marrow samples. The clonal relationship between trisomy 8 and tetrasomy 8 in these cases remains to be clarified. Patients with tetrasomy 8 have a poor prognosis, and only 1 out of 33 patients was free of disease 3 years after autologous bone marrow transplantation. Here, we report the case of a 25-year-old female patient with monocytic leukemia and tetrasomy 8.

Entities:  

Mesh:

Year:  2005        PMID: 16080962     DOI: 10.1016/j.cancergencyto.2004.12.016

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT.

Authors:  William Makis; Rajan Rakheja; Josee Lavoie; Marc Hickeson
Journal:  Nucl Med Mol Imaging       Date:  2012-02-14

2.  A case of acute myeloid leukemia (AML) with an unreported combination of chromosomal abnormalities: gain of isochromosome 5p, tetrasomy 8 and unbalanced translocation der(19)t(17;19)(q23;p13).

Authors:  Christian Paar; Gabriele Herber; Daniela Voskova; Michael Fridrik; Herbert Stekel; Jörg Berg
Journal:  Mol Cytogenet       Date:  2013-09-30       Impact factor: 2.009

3.  Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18.

Authors:  Michael Maher; Jeannine Diesch; Marguerite-Marie Le Pannérer; Marta Cabezón; Mar Mallo; Sara Vergara; Aleix Méndez López; Alba Mesa Tudel; Francesc Solé; Marc Sorigue; Lurdes Zamora; Isabel Granada; Marcus Buschbeck
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.